Support for the technical report came from the AAP and the IU School of Medicine's Department of Pediatrics.
Aaron Carroll, MD, associate professor of pediatrics at the IU School of Medicine, is also a co-author of the new study. Downs and Carroll are Regenstrief Institute affiliated scientists. Finnell sees patients in the infectious disease clinic at Riley Hospital for Children at Indiana University Health. Downs and Carroll see patients at Wishard Hospital. The IU School of Medicine and the Regenstrief Institute are located on the Indiana University-Purdue University Indianapolis campus.
"The AAP is the authoritative source of pediatric guidelines in the United States and beyond. This change in recommendations will have a substantial impact on clinical practice," said Stephen M. Downs, M.D., professor of pediatrics at the IU School of Medicine and co-author of the new technical report. Dr. Downs was the author of a 1999 technical report that informed the earlier AAP guideline.
"Technical ReportDiagnosis and Management of an Initial UTI in Febrile Infants and Young Children" accompanies the AAP's new clinical practice guidelines "Clinical Practice GuidelineDiagnosis and Management of Initial UTIs in Febrile Infants and Children Aged 2 to 24 Months."
"If there is no obvious source of fever, the pediatrician needs to think UTI and needs to test for it. But we need to now change what we do after we have treated that first episode of UTI. We, as physicians, have been fooling ourselves by putting young patients on long-term antibiotics and thinking that would prevent the patient from getting another UTI," says S. Maria Finnell, MD, assistant professor of pediatrics at the IU School of Medicine, lead author of the technical report and an author of the AAP policy statement.
In the 1999 guideline a radiologic test called a voiding cystourethrogram (VCUG) was recommended for young children after a first UTI. This was done to identify children with urine refluxing back up to the kidney. When identified, most of these children were started on prophylactic antibiotics in an attempt to prevent repeated episodes of UTI. But when the IU researchers reviewed studies done in the decade following the old 1999 guidelines, they found no benefit to long-term prophylactic antibiotics. Given that antibiotics do not work, they determined there was no reason to put all these children through the pain and radiation of the VCUG.
UTIs are one of the most common bacterial infections in babies and toddlers. Five percent of children in this age group with fever and no other obvious fever source have UTI. Diagnosis and management are clinically challenging because the patients are unable to express their symptoms. Repeated UTIs can lead to kidney scarring and life-long decreased kidney function.
As a result of these findings, the AAP has updated its practice guideline on the diagnosis and management of initial UTIs in children aged two to 24 months. The report and the new AAP guideline appear in the September issue of the journal Pediatrics.
The findings of the IU School of Medicine investigators argue against exposing all young children who are diagnosed with an initial urinary tract infection (UTI) to a painful radiologic test and against prescribing prophylactic antibiotic treatment that may extend for years -- the diagnosis and management tools indicated in the American Academy of Pediatrics' current guideline, established in 1999. The new study was conducted at the request of the AAP.
Analysis by Indiana University School of Medicine researchers of 10 years of scientific studies has resulted in changes in American Academy of Pediatrics recommendations for how initial urinary tract infection (UTI) in infants and toddlers is diagnosed and treated. This change will affect thousands of children every year.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.